Rep. DeLauro’s FDA Plans: “Restore Oversight,” Increase Budget
This article was originally published in The Gray Sheet
Executive Summary
Rep. Rosa DeLauro (D-Conn.), expected to chair the House panel overseeing FDA's budget, wants to increase agency funding, but not without the caveat of enhanced congressional oversight
You may also be interested in...
House Ag Approps Chair Threatens FDA Management On Safety Role
The chair of the House Appropriations Agriculture Subcommittee is threatening to zero-out salaries of FDA center directors and heads of offices in fiscal 2008 as a consequence of failing to follow through on safety investigations
House Ag Approps Chair Threatens FDA Management On Safety Role
The chair of the House Appropriations Agriculture Subcommittee is threatening to zero-out salaries of FDA center directors and heads of offices in fiscal 2008 as a consequence of failing to follow through on safety investigations
CDRH Unveils Postmarket Safety “Action Items”
FDA's plan to strengthen postmarket device safety by making better use of postmarket data includes modifying its organizational infrastructure, updating adverse event reporting practices and potentially increasing the use of fines for certain types of industry noncompliance